HOME >> MEDICINE >> NEWS
Success of new treatment halts international blood pressure drug trial

An international trial comparing blood-pressure lowering treatments has been stopped early due to the significantly better performance of one of the treatments in the trial.

The 19,000 patient Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) has been comparing a new treatment strategy for hypertension against an old one, in order to discover which is better at preventing various cardiovascular events such as heart attacks and strokes.

The older treatment strategy based on the beta-blocker, atenolol and the thiazide diuretic, bendroflumethiazide was compared with a newer treatment strategy using the calcium channel blocker, amlodipine, and the angiotensin converting enzyme inhibitor, perindopril.

The blood pressure part of trial has been stopped because of cardiovascular benefits in favour of the newer calcium channel blocker plus angiotensin converting enzyme inhibitor treatment when compared with the beta-blocker, atenolol and the thiazide diuretic, bendroflumethiazide.

This announcement signals the end of the main clinical elements of the ASCOT trial, launched in 1997.

ASCOT study co-chairmen Bjrn Dahlf, from the Sahlgrenska University Hospital, stra, Sweden, and Peter Sever from Imperial College London, UK, comment: "This is excellent news for the many people who suffer from high blood pressure. Although at the moment we are unable to provide any definite figures on the effectiveness of the new treatments compared with the old, we have seen important significant differences."

The Steering Committee of ASCOT accepted on 18 November the recommendation of its Data Safety Monitoring Board that the blood pressure arm of the trial should be stopped and the majority of patients have now been informed.

The complete results of the ASCOT trial will be made available when all data up to and including the last individual patient visit have been collected and analysed. Investigators and patient
'"/>

Contact: Tony Stephenson
at.stephenson@imperial.ac.uk
44-20-759-46712
Imperial College London
8-Dec-2004


Page: 1 2

Related medicine news :

1. Success of liver transplantation may be most influenced by three risk factors
2. Success of experimental herpes vaccine builds momentum for human clinical trials
3. Successful therapy for head and neck cancer may lead to long-term circulatory problems
4. Success of nicotine patches linked to genetic make-up
5. Successful, rapid protein crystallization possible with technique developed by UCSD researcher
6. Successful prostate surgery: Its quality of surgery not quantity that matters most
7. Successful implementation of pilot study for HIV antiretroviral therapy in Uganda
8. Successful measles vaccination feasible in low-income countries
9. Scientists analyze stroke studies from the past 50 years; Success rate of experimental drugs described as remarkably dismal
10. Success of plasma centers could hurt Red Cross, study finds
11. New Procedure Makes A Successful Transplant Possible

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2019)... ... 13, 2019 , ... Dr. Jig Patel and the dental professionals at ... talented and knowledgeable dentist from St. Louis, MO, to the team. With ... CEREC same-day dentistry, root canals and emergency treatment. Dr. Patel, Dr. Merchant and their ...
(Date:2/13/2019)... ... 13, 2019 , ... Surgery that moves both jaws forward – known as ... apnea (OSA), resulting in benefits that include improved breathing, daytime wakefulness and quality of ... MMA should be regarded as the preferred treatment for patients with moderate to severe ...
(Date:2/13/2019)... ... February 13, 2019 , ... The Haute Beauty Network, well ... David A. Lickstein as a leading breast expert and our newest addition to ... doctors. The invitation-only exclusive publication maintains elite as ever, with only two doctors ...
(Date:2/12/2019)... ... February 12, 2019 , ... Medical ... FDAnews and Ombu Enterprises**, Feb. 19-20, 2019, Atlanta, GA , https://www.fdanews.com/mdriskmanagement ... the Winds of Change on Jan. 22 , Risk management is just plain ...
(Date:2/12/2019)... ... February 12, 2019 , ... Accreditation Commission for ... Partnership for Home Care. This agreement allows Rhode Island Partnership for Home Care ... Accreditation services, as well as discounts on ACHCU educational resources that help prepare ...
Breaking Medicine News(10 mins):
(Date:2/14/2019)... ... February 14, 2019 , ... Shady Grove Fertility Atlanta ... McCarthy-Keith has been named Medical Director for the Atlanta region. This distinction ... the local Atlanta community in helping patients overcome infertility. In this role, Dr. ...
(Date:2/13/2019)... (PRWEB) , ... February 14, 2019 , ... ... insect repellent was granted approval by the California EPA for release and sale ... US. This is a major milestone in Entomol‘s commercial development. This registration opens ...
(Date:2/13/2019)... ... February 13, 2019 , ... Kno2 ®, ... as the recipients for the ‘Empower Your Care Teams and Employees’ category of ... the 2019 HIMSS Annual Conference and Exhibition in Orlando, Florida, recognize ...
Breaking Medicine Technology:
Cached News: